共 406 条
[1]
Sarzi-Puttini P(2010)Cardiac involvement in systemic rheumatic diseases: an update Autoimmun Rev 9 849-852
[2]
Atzeni F(2016)2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J 37 67-119
[3]
Gerli R(2019)Hemodynamic definitions and updated clinical classification of pulmonary hypertension Eur Respir J 53 1801913-3731
[4]
Bartoloni E(2022)2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 43 3618-1417
[5]
Doria A(2011)Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors Rheumatol Int 31 1409-18
[6]
Barskova T(2012)REVEAL: a contemporary US pulmonary arterial hypertension registry Eur Respir Rev 21 8-157
[7]
Matucci-Cerinic M(2009)Connective tissue disease-associated pulmonary arterial hype`rtension in the modern treatment era Am J Respir Crit Care Med 179 151-437
[8]
Sitia S(2017)Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China Int J Cardiol 236 432-9
[9]
Tomasoni L(2012)Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry Int J Rheum Dis 15 e80-1030
[10]
Turiel M(2006)Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 1023-131